Natalizumab De-escalation With Interferon Beta-1b

Clinical trial NCT01144052 · COMPLETED

Trial details

NCT number: NCT01144052
Sponsor: Claudio Gobbi
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Relapsing-remitting Multiple Sclerosis

Start date: 2010-06-01
Primary completion: 2011-11-01
Enrollment: 19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.